|
TMEM106A expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.211200E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.718800E-01 |
| Normal-vs-Stage2 |
2.505400E-01 |
| Normal-vs-Stage3 |
4.227500E-02 |
| Normal-vs-Stage4 |
6.504400E-02 |
| Stage1-vs-Stage2 |
1.559350E-01 |
| Stage1-vs-Stage3 |
3.417900E-04 |
| Stage1-vs-Stage4 |
3.577800E-03 |
| Stage2-vs-Stage3 |
3.229600E-01 |
| Stage2-vs-Stage4 |
4.438800E-01 |
| Stage3-vs-Stage4 |
8.908200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.101600E-01 |
| Normal-vs-AfricanAmerican |
2.550100E-02 |
| Normal-vs-Asian |
9.098800E-01 |
| Caucasian-vs-AfricanAmerican |
2.271600E-02 |
| Caucasian-vs-Asian |
8.173000E-01 |
| AfricanAmerican-vs-Asian |
2.586200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.501800E-02 |
| Normal-vs-Female |
5.544000E-01 |
| Male-vs-Female |
3.53010000000431E-05 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.746000E-02 |
| Normal-vs-Age(41-60Yrs) |
4.970400E-01 |
| Normal-vs-Age(61-80Yrs) |
2.338000E-01 |
| Normal-vs-Age(81-100Yrs) |
7.040000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.427600E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.508100E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.920200E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.260000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.834400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.377230E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.451400E-01 |
| Normal-vs-Grade 2 |
8.719000E-01 |
| Normal-vs-Grade 3 |
2.904600E-01 |
| Normal-vs-Grade 4 |
3.576600E-03 |
| Grade 1-vs-Grade 2 |
1.901800E-01 |
| Grade 1-vs-Grade 3 |
3.190400E-02 |
| Grade 1-vs-Grade 4 |
1.900420E-02 |
| Grade 2-vs-Grade 3 |
1.075230E-01 |
| Grade 2-vs-Grade 4 |
1.95069999997521E-06 |
| Grade 3-vs-Grade 4 |
6.210000E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
5.935800E-02 |
| Normal-vs-ccB subtype |
1.416700E-03 |
| ccA subtype-vs-ccB subtype |
1.11022302462516E-16 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.604200E-01 |
| Normal-vs-N1 |
3.375000E-01 |
| N0-vs-N1 |
3.887600E-01 |
|
|
